Salix announced that the FDA has approved Fulyzaq (crofelemer) delayed-release tablets for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy ...

Salix announced that the FDA has granted priority review designation of its New Drug Application (NDA) for crofelemer 125mg tablets for the control and symptomatic relief of diarrhea in patients with ...

Considering taking supplements to treat Hiv aids related diarrhea? Below is a list of common natural remedies used to treat or reduce the symptoms of Hiv aids related diarrhea. Follow the links to ...

Advanced immunosuppression from HIV infection can lead to gastrointestinal symptoms such as diarrhea, nausea, vomiting, dysphagia, weight loss, and abdominal pain. There is a complex, combined effect ...

The US Food and Drug Administration (FDA) today approved crofelemer (Fulyzaq, Salix Pharmaceuticals under license from Napo Pharmaceuticals, Inc) to relieve diarrhea in patients with HIV/AIDS who are ...

HIV is often surrounded by stigma, misinformation and silence. As a result, many people are unaware of the crucial symptoms that accompany it, leading to missed opportunities for early diagnosis and ...

This is a preview. Log in through your library . Abstract Campylobacter upsaliensis was isolated from the feces of 20 human immunodeficiency virus (HIV)-infected patients with diarrhea over a 67-month ...

Finding out you have HIV can jolt your world. Fortunately, it can be a manageable long-term condition, not unlike diabetes or heart disease. With treatment, many Americans who have HIV live almost as ...

The first signs of HIV may include a fever, muscle soreness, fatigue, or other flu-like symptoms. Some people experience no initial symptoms, which is why getting tested frequently is important. The ...

So begins “Let’s Talk About (Surprise) Diarrhea,” an original song at the heart of Napo Pharmaceuticals’ “Surprise Diarrhea Lip-Syncing and Singing Contest,” launched Wednesday to mark National Gay ...

Descovy, a daily pre-exposure prophylaxis treatment, is approved to reduce the risk of contracting HIV upon exposure to the virus. The drug, manufactured by Gilead, is designed for at risk adults and ...